In vitro model reveals dynamic changes in BBB integrity and ionic balance during ischemic stroke, suggesting new pathways for investigation.
Ischemic stroke is a leading cause of death and disability worldwide, resulting in blood-brain barrier (BBB) disruption and ionic homeostasis imbalance. However, existing models lack the ability to simultaneously monitor BBB integrity and ionic homeostasis during ischemic stroke. Here, we developed a BBB-on-a-chip integrated with transendothelial electrical resistance (TEER) and ion sensors. With this chip, we constructed an in vitro BBB model and employed oxygen-glucose deprivation/reperfusion (OGD/R) to mimic ischemic stroke, with electrodes integrated into both sides enabling continuous in situ monitoring of TEER and extracellular K⁺. Experiments show that the model forms a high-integrity barrier under normal conditions, with the TEER value reaching 200.18 Ω·cm², confirming its physiological relevance. During OGD injury, TEER significantly decreased by 46.41%, while it partially recovered to about 73% of the control group after reperfusion. Simultaneous K⁺ monitoring showed that under normal conditions, the K⁺ concentration decreased; during the OGD, it increased sharply by about 23.8%, followed by a corresponding reduction after reperfusion. By integrating electrodes for multiparameter in situ detection, we revealed the dynamic relationship between BBB integrity and K⁺ concentration changes during the ischemic stroke process, providing a powerful tool for investigating the ischemic stroke pathological process and conducting drug screening.
No takes yet. Share an insight, caveat, or question.
Kuang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: